615 filings
Page 2 of 31
8-K
688uyec
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
3sgcws bhe3k
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
PX14A6G
1go788wf
18 May 23
Letter to shareholders
4:46pm
DEFA14A
hok35fk h4
17 May 23
Additional proxy soliciting materials
4:04pm
8-K
5zqrbkp o21
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
ARS
cpgur06cduhg9gbx2553
21 Apr 23
Annual report to shareholders
4:09pm
DEFA14A
e0s1uaohy
21 Apr 23
Additional proxy soliciting materials
4:03pm
8-K
jorhzigmx jyid4
17 Apr 23
Departure of Directors or Certain Officers
7:37am
8-K
hkej2
10 Apr 23
Results of Operations and Financial Condition
7:01am
8-K
o8noou61fm
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
oyumdz0 sem6gj0h7
3 Feb 23
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
7:06am
8-K
kjhf9kag
9 Jan 23
J.P. Morgan Healthcare Conference 2023 Strategy & Business Update 2 Leonard S. Schleifer, MD, PhD Co - Founder, President & Chief Executive Officer
8:49am
8-K
41x0ffq54c
20 Dec 22
Entry into a Material Definitive Agreement
4:01pm
UPLOAD
uqlpe
7 Nov 22
Letter from SEC
12:00am
8-K
lkbmwo3
3 Nov 22
Regeneron Reports Third Quarter 2022 Financial and Operating Results
7:19am
CORRESP
lo919lx 7eaujh
7 Oct 22
Correspondence with SEC
12:00am